The possible role of MEG3 in MS may arise from the ability of this lncRNA to modulate inflammatory response via sponging of miR-138, which regulates IL-1β level [68]; IL-1β is known to participate in EAE and MS [69]. This evidence concerns the gene MEG3 and myeloid sarcoma.